$ USD
¥ 人民币
$ USD
€ 欧元
English
简体中文
English
繁体中文
Sign In / Sign up
Home page
News
Tumor Information
Tumor Information
Tumor medication
Tumor medication
Drug data
Drug data
Tumor medication
Oncology
renal cell carcinoma
cell tumor
solid tumors
IDH1 mutation
non-small cell lung cancer
neurofibromatosis
liposarcoma
neurofibromatosis
Cachexia
bladder cancer
Common Medications
Common medications
Hematology
Hepatobiliary
chronic disease
Endocrinology
Rare disease drugs
Other medications
insomnia
depression
chronic cough
kidney transplant
Drug Classification
Brand Medicine Search
Brand Medicine Search
日本日医工株式会社
日本盐野义制药
日本杏林制药株式会社
日本株式会社
老挝卢修斯
hormone receptor positive
constipate
heart disease
constipate
depression
日本株式会社
日本田边三菱
英国FuturaMedical制药
日本盐野义制药
日本杏林制药株式会社
Medical Q&A
Medical Q&A
About Us
About Us
Menu
Home page
News
Tumor Information
Tumor Information
Tumor medication
Tumor medication
Drug data
Drug data
Tumor medication
Oncology
renal cell carcinoma
cell tumor
solid tumors
IDH1 mutation
non-small cell lung cancer
neurofibromatosis
liposarcoma
neurofibromatosis
Cachexia
bladder cancer
Common Medications
Common medications
Hematology
Hepatobiliary
chronic disease
Endocrinology
Rare disease drugs
Other medications
insomnia
depression
chronic cough
kidney transplant
Drug Classification
Brand Medicine Search
Brand Medicine Search
日本日医工株式会社
日本盐野义制药
日本杏林制药株式会社
日本株式会社
老挝卢修斯
hormone receptor positive
constipate
heart disease
constipate
depression
日本株式会社
日本田边三菱
英国FuturaMedical制药
日本盐野义制药
日本杏林制药株式会社
Medical Q&A
Medical Q&A
About Us
About Us
Home
News
News
Medical Halo Global Pharmaceutical News_Targeted Drugs_New Anti-Cancer Drugs_Overseas Medical Information_【Medical Halo Global Pharmaceutical】
阿巴西普注射液治疗什么病的
2025-10-19 11:44:20
Check Details
巴瑞克替尼适应人群
2025-10-19 11:44:20
Check Details
巴瑞克替尼说明书
2025-10-19 11:44:20
Check Details
巴瑞克替尼要终生服用吗
2025-10-19 11:44:20
Check Details
巴瑞克替尼治疗类风湿多少钱
2025-10-19 11:44:20
Check Details
巴瑞克替尼治疗类风湿吗
2025-10-19 11:44:20
Check Details
巴瑞克替尼治疗类风湿有效吗
2025-10-19 11:44:20
Check Details
巴瑞克替尼治疗什么病
2025-10-19 11:44:20
Check Details
巴瑞克替尼治什么病
2025-10-19 11:44:20
Check Details
巴瑞克替尼中国的价格
2025-10-19 11:44:20
Check Details
托法替尼说明书
2025-10-19 11:44:20
Check Details
碧康托法替尼价格
2025-10-19 11:44:20
Check Details
1
2
...
2761
2762
2763
2764
2765
2766
2767
...
10240
10241
Category
Oncology
Hepatobiliary
dermatology
Endocrinology
Hematology
Andrology
Gynecology
Nephrology
Urology
Department of Infectious Diseases
Gastroenterology
Respiratory department
Neurology
Cardiology and Brain Department
ophthalmology
Psychiatry
Immunology Department
orthopedics
Burn Department
相关知识
1
Cabozantinib Overview: Multi-Target TKI Efficacy and Safety Monitoring for Bleeding, Hypertension, Thrombosis
2
FDA Approves Sunharbo (asundexian), the World’s First FXIa Inhibitor, to Reduce Stroke Risk in Adults with Recent Non‑Cardioembolic Ischemic Stroke or High‑Risk TIA
3
Sotorasib (Lumakras): Indications, Dosing, Safety and the Next-Gen KRAS G12C Landscape
4
Momelotinib for Myelofibrosis: Spleen Response, Symptom Improvement and Efficacy Monitoring
5
Pirtobrutinib and Risks of Atrial Fibrillation and Bleeding: Mechanism, Data Interpretation and Monitoring
6
Weight Gain and Edema Management, Monitoring of Repotrectinib (Augtyro) During Treatment
7
Ixazomib (Ninlaro) Dosing Schedule, Missed Dose Management and Cycle Planning in 28‑Day Regimen
8
Ponatinib in the PACE Phase II Trial: Response Data in Resistant CML and Ph+ ALL
9
Selumetinib for NF1-Related Plexiform Neurofibromas: Time to Response and Response Assessment
10
How to Take Tucatinib (Tukysa): Dosing Schedule, Combination Use & Missed Dose Guidance
11
Ganaxolone Common Side Effects: Somnolence, Sedation and Safety Notes
12
Baxdrostat: Efficacy and Safety of a Novel Aldosterone Synthase Inhibitor